By Lisa Vies, Global Information Network
NW YORK (IDN) – The South African firm Aspen may soon be rolling out drugs to combat COVID-19 on the continent after signing a deal with the U.S.-based Johnson & Johnson.
The American pharma company has conducted the only major study testing the efficacy of a single dose of Covid vaccine among 60,000 volunteers. In October, the company announced that the single-dose drug “induced a strong neutralizing antibody response in nearly all participants aged 18 years and older and was generally well tolerated.”